N-(4-Aminobutyl)-N-methyl carbamic acid tert-butylester, 95.0%, 5g

Hexahidrato de nitrato de cobalto(II), mínimo 98 %, pa, ACS, 100 g, envase de plástico.

3-(4-Sulfamoyl-phenyl)-propionic acid, 95.0%, 5g

N-(4-Chloro-3-cyano-7-ethoxy-6-quinolinyl)acetamide, 95.0%, 5g

2-Amino-7-hydroxy-1,8-naphthyridine, 95.0%, 5g

6-Chloroquinoxaline-2,3-diol, 95.0%, 1g

5-Amino-1-methylindolin-2-one, 95.0%, 2.5g

O-[(Ethoxycarbonyl)cyanomethylenamino]-N,N,N',N'-tetramethyluronium Hexafluorophosphate>98.0%(HPLC)(N)5g

2-Bromoethyl phenyl sulfide, 97.0%, 5g

8-chloro-2-methyl-1,4-dihydroquinazolin-4-one, 98%, 25g

7-Bromo-2-methylimidazo[1,2-a]-pyridine-3-carboxylic acid, 97%, 10g

1'-methyl-3,5,6,7-tetrahydrospiro[imidazo[4,5-c]pyridine-4,4'-piperidine], 95.0%, 1g

4-Chloro-3-fluoropyridine-2-carboxylic acid, 97%, 250mg